Profile | GDS2987 / GI_13384601-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | 17.9 | 42 |
GSM215253 | HMVEC_vehicle_rep3 | ||
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 7.6 | 16 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | ||
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 26 | 41 |
GSM215297 | PASMC_vehicle_rep1 | 85.8 | 71 |
GSM215298 | PASMC_vehicle_rep2 | 71.1 | 68 |
GSM215310 | PASMC_vehicle_rep3 | 59.3 | 65 |
GSM215311 | PASMC_atorvastatin_rep1 | 137.8 | 78 |
GSM215312 | PASMC_atorvastatin_rep2 | 89.3 | 72 |
GSM215313 | PASMC_atorvastatin_rep3 | 133.2 | 77 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 132.6 | 77 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 135.6 | 77 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 101.6 | 74 |
GSM215327 | PASMC_SLx2119_rep1 | 88.1 | 73 |
GSM215328 | PASMC_SLx2119_rep2 | 97.3 | 74 |
GSM215329 | PASMC_SLx2119_rep3 | 26.5 | 45 |
GSM215330 | Fibroblasts_vehicle_rep1 | 167.4 | 80 |
GSM215331 | Fibroblasts_vehicle_rep2 | 157 | 79 |
GSM215332 | Fibroblasts_vehicle_rep3 | 171.5 | 80 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 197.2 | 82 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 138.4 | 78 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 145.3 | 78 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 106 | 76 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 112.4 | 77 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 85.1 | 73 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 138.3 | 78 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 125.8 | 77 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 95.8 | 75 |